Uses of polypills for cardiovascular disease and evidence to date

Polypills have been approved in more than 30 countries, but worldwide experience with and availability of polypills remain limited, unlike fixed-dose combinations in other diseases such as HIV, tuberculosis, and malaria. In this Series review, we aim to propose a guide for the use of polypills in fu...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The Lancet (British edition) Ročník 389; číslo 10073; s. 1055 - 1065
Hlavní autori:	Huffman, Mark D, Xavier, Denis, Perel, Pablo
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Elsevier Ltd 11.03.2017 Elsevier Limited
Predmet:	Atherosclerosis Cardiovascular disease Cardiovascular diseases Disease prevention Drug dosages Drug therapy Health risk assessment Heterogeneity Internal Medicine Lipids Malaria Pharmaceutical industry Prevention Purchasing contracts Risk assessment Risk factors Studies Tuberculosis Vector-borne diseases
ISSN:	0140-6736, 1474-547X, 1474-547X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!